Results 251 to 260 of about 289,721 (318)

Retraction: Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow. [PDF]

Cureus
Kumar DS, Prasanth K, Bhandari A, Kumar Jha V, Naveen A, Prasanna M.   +5 more
europepmc   +1 more source

Continuing as Partners in Immunization: Building Immunization Confidence Through Communication, Education, and Resources. [PDF]

J Pediatr Pharmacol Ther
Girotto JE, Warminski S, Oz T, Hunter Fly J, Cavness AA, Kubes SE.   +5 more
europepmc   +1 more source

Correction: Formulation of zein nanoparticles for augmenting the anti-inflammatory activity of dexketoprofen. [PDF]

Front Pharmacol
El Hassab MA, Ibrahim MH, Abdel Mageed SS, Mahmoud AMA, Othman Ahmed ZS, Mosallam S, Abdelbari MA, Khaleel EF, El Hasab MA, Elsayyad A, Allam S, Eltabeeb MA, Negmeldin AT, Eldehna WM, Albash R.   +14 more
europepmc   +1 more source

Editorial Expression of Concern: Bioactive fraction from Plumeria obtusa L. attenuates LPS‑induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC/QToF‑MS and molecular docking. [PDF]

Inflammopharmacology
Eloutify YT, El-Shiekh RA, Ibrahim KM, Hamed AR, Al-Karmalawy AA, Shokry AA, Ahmed YH, Avula B, Katragunta K, Khan IA, Meselhy MR.   +10 more
europepmc   +1 more source

Oncology Meets a New Collaborator-Clinical Pharmacology: Safer, Personalized Therapy for Better Outcomes and Patient Quality of Life. [PDF]

Hosp Pharm
Belančić A, Golčić M, Marušić J, Mikolašević I.   +3 more
europepmc   +1 more source

Drug-induced mania and parkinsonism in substance use disorder patient: A case report.

Indian J Pharmacol
Gurumoorthi R, Rajendran RS, Murugan A, Thiyagarajan K, Rajanandh MG.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacy and pharmacology of biosimilars

Journal of Endocrinological Investigation, 2008
Biosimilar medicines are biological medicinal products that can obtain a marketing authorization in the EU after the original product (biological reference medicine) has run out of patent. As a prerequisite, studies including clinical trials are to be conducted to compare the quality, safety, and efficacy of the biosimilar and reference medicine.
I. Krämer
openaire   +3 more sources

History of Clinical Pharmacy and Clinical Pharmacology

The Journal of Clinical Pharmacology, 1981
Abstract: The purpose of the Symposium on Clinical Pharmacy and Clinical Pharmacology is to describe the present and future functional roles of clinical pharmacists and clinical pharmacologists in drug research, professional education, and patient care. Clinical pharmacy is a relatively new professional discipline, being only about 15 years old.
Russell R. Miller
openaire   +3 more sources

African Journal of Pharmacy and Pharmacology

2017
Since antimicrobials are used to fight infectious diseases, their proper use is a major world concern. The use of more than one medicine in the treatment of infectious disease is controversial hence the association therapy is used empirically to treat ...
H. Gupta
openaire   +2 more sources

An Overview of Clinical Pharmacy and Clinical Pharmacology

The Journal of Clinical Pharmacology, 1981
Abstract: The relationship between clinical pharmacy and clinical pharmacology can best be assessed by looking at the three major responsibilites of these related professional disciplines—research, education, and patient care. Clinical pharmacologists will continue to dominate clinical research, but clinical pharmacists will continue to expand their ...
Russell R. Miller
openaire   +3 more sources